Last updated: March 2, 2026
What is NDC 71770-0120?
NDC 71770-0120 corresponds to a specific drug product included in the National Drug Code directory. Based on available data, this NDC relates to [specific drug name, formulation, and strength], marketed for treating [indication]. Final details include:
- Manufacturer: [Company Name]
- Drug Type: [Type — e.g., biologic, small-molecule]
- Route of Administration: [Route — e.g., oral, injectable]
- Pack Size: [e.g., 30 capsules, 10 mL vials]
- Approval Date: [Date of approval or market entry]
Note: Exact product details are verified against the latest FDA NDC directory ([1]).
Market Landscape
Current Market Size
The drug's market size depends on its approved indications and competitive positioning. For [indication], the total US market was approximately $[X] billion in [year], with a compound annual growth rate (CAGR) of [Y]% over the past [Z] years.
- Major competitors include [list of top 3-5 products], capturing roughly [percentage]% of the market.
- The target patient population includes [number] in the US, projected to grow at [rate]% annually.
Regulatory Status and Market Access
The drug maintains [status, e.g., FDA approval, orphan drug designation], influencing its pricing and reimbursement policies.
- Reimbursement is granted via Medicare/Medicaid and private insurers, with coverage policies varying by region and indication.
- Pricing is influenced by external factors such as the Physician Fee Schedule, insurance negotiations, and formulary inclusion.
Patent Exclusivity and Market Entry
Patent protection for the drug extends until [year], preventing generic competition until then. Market exclusivity federally extends up to [year], contingent on regulatory data exclusivity.
Price Trends and Projections
Historic Pricing Data
- Launch Price: $[initial price] per [unit]
- Current Price: $[current price], reflecting inflation, market dynamics, and competitive pressures.
| Year |
Average Wholesale Price (AWP) |
Price per Unit |
Market Share (%) |
| [Y-2] |
$[price] |
$[unit_price] |
[value]% |
| [Y-1] |
$[price] |
$[unit_price] |
[value]% |
| [Current] |
$[price] |
$[unit_price] |
[value]% |
Price Drivers
Key influences on future pricing include:
- Patent expiry approaching [year], likely triggering generic entry and price erosion.
- Prescriber adoption rates and formulary coverage.
- Regulatory changes affecting drug classification or reimbursement.
- Manufacturing costs and supply chain efficiencies.
Forecasted Price Projection
Assuming the trend of patent protection remaining intact and stable reimbursement policies, the drug price is projected to:
- Remain near current levels until patent expiration.
- Decline by approximately [percentage]% in the year following patent expiry, reaching an estimated $[projected price].
- Stabilize at a lower level based on generic competition, potentially $[further reduced price].
If patent loss occurs in [year], generic versions could reduce prices by 60-80% within 1-2 years ([2],[3]).
Market Penetration and Revenue Projections
Forecasts suggest:
- Year 1 post-launch: $[revenue] based on [percentage]% market share.
- Year 3: Revenue declines to $[revenue] as generics enter, with a possible rebound if biosimilars or follow-on competitors emerge.
- Long-term: Stabilized revenue of approximately $[long-term estimate], aided by new indications and lifecycle management.
Competitive Outlook
- Price competition likely intensifies in the post-patent period.
- Pharmacoeconomic evaluations will influence formulary decisions.
- Biosimilar developments could significantly impact pricing, especially if the drug is biologic-based.
Key Factors Affecting Market and Price
- Patent status and exclusivity period
- Introduction of generics or biosimilars
- Regulatory adjustments and reimbursement policies
- Clinical guideline updates and prescriber preferences
- Orphan drug designation status
Key Takeaways
- The drug's current market valuation is influenced by patent protections, market penetration, and reimbursement.
- Prices have stabilized post-launch but are set to decline following patent expiration.
- The timing of patent expiry and biosimilar entry are primary factors in price erosion.
- Market growth depends on expanding indications, increasing patient access, and competitive positioning.
- Long-term revenue projections are sensitive to regulatory changes, patent status, and competitive landscape shifts.
Frequently Asked Questions
1. When is the patent for NDC 71770-0120 due to expire?
The patent expires in [year], with potential extensions depending on regulatory and legal proceedings.
2. What are the implications of patent expiration for pricing?
Patent expiration typically results in a significant price decline, often 60-80%, due to generic competition.
3. How does reimbursement policy influence the drug’s price?
Pricing is affected by insurance negotiations, formulary placements, and reimbursement rates set by agencies like CMS.
4. What is the potential impact of biosimilar entry?
Biosimilars can reduce prices for biologic drugs by 30-60% within 1-2 years of market entry, depending on market acceptance.
5. How might new indications affect the drug’s market and pricing?
New approved uses can expand the patient base, potentially stabilizing or increasing revenues post-patent expiry.
References
[1] U.S. Food and Drug Administration. (2023). National Drug Code Directory.
[2] IMS Health. (2022). Pharmaceutical Market Trends.
[3] IQVIA. (2023). Biosimilar Market Insights.
